JAMES W. FORSYTHE, M.D., H.M.D. received his Bachelor of Science Degree in Biochemistry and Physiology from the University of California, Berkeley in 1960 and his Medical Degree from the University of San Francisco in 1964. He did his Residency in Medicine at Children’s Hospital, San Francisco in 1971. Dr. Forsythe received a Fellowship in Oncology-Hematology at the Cancer Research Institute, University of California, San Francisco, General Hospital in 1973. Dr. Forsythe received his Subspecialty of Medical Oncology in 1982. He studied under the British Institute of Homeopathy and received his Homeopathic Certificate in 1996.
Since 1986, Dr. Forsythe became interested in combining Conventional and Complementary Medicine. He was the only Medical Oncologist in the Reno, Nevada area that would treat cancer patients who were under the care of an Alternative Physician. He noted that patients who were integrating cancer therapies were doing far superior and had a better quality of life than those patients who were under conventional cancer care.
Dr. Forsythe became interested in carrying out Clinical Outcome-based Survival Studies in order to validate the efficacy of Integrative Cancer Therapies. He has completed and continues his studies on Paw-Paw, Poly-MVA and Glyco Nutrients. Dr. Forsythe is now usingEnercel and Folium Pine for an outcome-based investigation on all Stage IV adult cancer patients.
Dr. Forsythe will present his data on his Forsythe Immune Therapy (F.I.T.) which contains a proprietary blend of vitamins, minerals, trace elements and herbs. In 2005 Dr. Forsythe added Poly-MVA and Glyco-Benzaldehyde to his F.I.T. proprietary mixture, to conduct a clinical outcome-based investigation. The study as to this date, September 2010 includes 500 Stage IV Adult Cancer Patients over a 5-year period. The mechanism of action on cancer cell metabolism by the Forsythe Immune Therapy and the action of Poly-MVA and Glyco-Benzaldehyde on the energetics of the malignant cell activity is synergistic. The 5-year results will be presented showing a 45% overall response rate.
Dr. Forsythe has been highly regarded as one of the leading Medical Oncologists in the United States. He is internationally recognized for his cancer treatments and known for his courageous fight against the FDA to allow all physicians nationally to treat Adult Onset Human Growth Deficiency. He is a renown author and Dr. Forsythe was the only Board Certified Medical Oncologist to be featured in Suzanne Somers’ best seller, Knockout: Interviews with Doctors Who Are Curing Cancer—And How to Prevent Getting It in the First Place. Dr. Forsythe has published numerous books and just completed his most recent book Compassionate Oncology.
He will speak on The Latest Clinical Study Of 1,000 Stage IV Cancer Patients Over 6 Years Showing A 71% Survival Rate.
AL SANCHEZ, JR., a former college instructor, entrepreneur and current president of Amarc Enterprises, is a member for the Foundation for Advancement in Cancer Research, an organization founded in 2004. After losing both his mother, Julia, and sister, Tina, to colon cancer, he committed to joining his family, friends and colleagues in their quest to find better options, access to information, treatments, and hopefully one day a cure for those stricken with such a devastating disease.
Al speaks at various health conferences throughout the world and shares with audiences his experience and research on degenerative disease and his knowledge of health that has helped many people find answers, hope and a better quality of life in many situations. He is committed to the Foundation’s mission to seek out promising, validated complementary/integrative treatment methods, to actively educate the public about them and to support and assist in funding research for development of integrative and safe treatments to help others. He, like so many others, is dedicated to the belief that we can vastly improve the Health of the World with educated choices, improved diet and lifestyle combined with natural products that can change the lives of our families and friends in our struggle, especially in cancer and other degenerative diseases, one person at a time.